These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 17926114

  • 1. Determinants of patient satisfaction with photodynamic therapy for neovascular age-related macular degeneration or polypoidal choroidal vasculopathy.
    Yamashiro K, Tsujikawa A, Nishida A, Kurimoto Y.
    Jpn J Ophthalmol; 2007; 51(5):368-374. PubMed ID: 17926114
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Visual outcome of photodynamic therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy over 5 years of follow-up.
    Miki A, Honda S, Kojima H, Nishizaki M, Nagai T, Fujihara M, Uenishi M, Kita M, Kurimoto Y, Negi A, Hyogo Macular Disease Study Group.
    Jpn J Ophthalmol; 2013 May; 57(3):301-7. PubMed ID: 23508554
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Five-year visual outcomes of typical age-related macular degeneration and/or polypoidal choroidal vasculopathy patients who received photodynamic therapy (PDT) as initial treatment in comparison with patients prior to the PDT era].
    Hata M, Mandai M, Kojima H, Kameda T, Miyamoto N, Kurimoto Y.
    Nippon Ganka Gakkai Zasshi; 2012 Oct; 116(10):937-45. PubMed ID: 23285841
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a 30-month multicenter study in Hyogo, Japan.
    Honda S, Kurimoto Y, Kagotani Y, Yamamoto H, Takagi H, Uenishi M, Hyogo Macular Disease Study Group.
    Jpn J Ophthalmol; 2009 Nov; 53(6):593-597. PubMed ID: 20020237
    [Abstract] [Full Text] [Related]

  • 7. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions.
    Tsuchiya D, Yamamoto T, Kawasaki R, Yamashita H.
    Retina; 2009 Nov; 29(7):960-5. PubMed ID: 19491727
    [Abstract] [Full Text] [Related]

  • 8. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Tano Y.
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P, van den Bergh H, Sickenberg M, Koh AH.
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [Abstract] [Full Text] [Related]

  • 10. Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.
    Imai H, Honda S, Nakanishi Y, Yamamoto H, Tsukahara Y, Negi A.
    Br J Ophthalmol; 2006 Dec; 90(12):1524-30. PubMed ID: 16825279
    [Abstract] [Full Text] [Related]

  • 11. [Assessment of visual acuity in patients with age-related macular degeneration 1 year after photodynamic therapy].
    Tsuzuki K, Honda M.
    Nippon Ganka Gakkai Zasshi; 2010 Jun; 114(6):520-6. PubMed ID: 20593657
    [Abstract] [Full Text] [Related]

  • 12. [Two-year results following photodynamic therapy for age-related macular degeneration].
    Yanagidaira T, Arai J, Yoshida N, Arai S, Fukui E, Imai H, Sugimoto T, Nakamura S, Murata T.
    Nippon Ganka Gakkai Zasshi; 2008 Dec; 112(12):1068-75. PubMed ID: 19157027
    [Abstract] [Full Text] [Related]

  • 13. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy.
    Yodoi Y, Tsujikawa A, Kameda T, Otani A, Tamura H, Mandai M, Yoshimura N.
    Am J Ophthalmol; 2007 Jun; 143(6):984-994. PubMed ID: 17336913
    [Abstract] [Full Text] [Related]

  • 14. Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan.
    Honda S, Imai H, Yamashiro K, Kurimoto Y, Kanamori-Matsui N, Kagotani Y, Tamura Y, Yamamoto H, Ohoto S, Takagi H, Uenishi M, Negi A.
    Ophthalmologica; 2009 Jun; 223(5):333-8. PubMed ID: 19478533
    [Abstract] [Full Text] [Related]

  • 15. Polypoidal choroidal vasculopathy in Taiwanese patients.
    Chang YC, Wu WC.
    Ophthalmic Surg Lasers Imaging; 2009 Jun; 40(6):576-81. PubMed ID: 19928723
    [Abstract] [Full Text] [Related]

  • 16. Practicability confirmation by meta-analysis of intravitreal ranibizumab compared to photodynamic therapy to treat polypoidal choroidal vasculopathy.
    Liu L, Ma J, Duan P, Liu Y, Yin ZQ.
    Mol Vis; 2015 Jun; 21():1130-41. PubMed ID: 26539025
    [Abstract] [Full Text] [Related]

  • 17. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
    Baek J, Lee JH, Jung BJ, Kook L, Lee WK.
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
    [Abstract] [Full Text] [Related]

  • 18. Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Nakai S, Matsumiya W, Miki A, Honda S, Nakamura M.
    Jpn J Ophthalmol; 2019 Sep; 63(5):389-395. PubMed ID: 31376050
    [Abstract] [Full Text] [Related]

  • 19. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Jain P, Anantharaman G, Gopalakrishnan M, Goyal A.
    Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.